Phenobarbital 24 mg/ml/Homatropine Methylbromide 0.27 mg/ml Oral Drops is a specially compounded medication designed to treat a range of conditions such as seizures, anxiety, and insomnia. This unique formulation combines two active ingredients, phenobarbital and homatropine methylbromide, to provide a more comprehensive treatment than either ingredient could offer on its own.

Phenobarbital is a barbiturate that functions as both a sedative and an anticonvulsant, helping to calm the nervous system and prevent seizures. Homatropine methylbromide, on the other hand, is an anticholinergic that aids in reducing the potential side effects of phenobarbital. The combination of these two ingredients creates a potent and effective treatment for the aforementioned conditions.

This medication is dispensed in a liquid form via a dropper bottle, which allows for precise and controlled administration. This is particularly beneficial for medications that require smaller doses or for pediatric patients who may have difficulty swallowing tablets or capsules. The oral drop form also allows for easy dose adjustments as needed.

While this formulation can be used by both adults and children, it is crucial to note that it should only be administered under the supervision of a healthcare provider. This is due to the potential for serious side effects if the medication is not used correctly. Additionally, this formulation may interact with other medications, so it is essential for patients to discuss all current medications with their healthcare provider before starting this treatment.

At Bayview Pharmacy, we take pride in offering this compounded medication as part of our extensive range of services. If you have any questions about this formulation or how it can be used to treat your specific condition, please do not hesitate to contact us. Our team of experienced compounding pharmacists is always here to assist you.

This compounded formulation of Phenobarbital 24 mg/ml and Homatropine Methylbromide 0.27 mg/ml is dispensed as oral drops. It is designed for precise and controlled administration, making it suitable for patients requiring smaller doses or for pediatric patients who may have difficulty swallowing tablets or capsules.

The formulation is indicated for the treatment of various disease states. However, it should not be used in patients with known hypersensitivity to either Phenobarbital or Homatropine Methylbromide. Special caution should be exercised in patients with renal or hepatic impairment, as well as in those with a history of glaucoma or urinary retention.

Patients are advised to avoid alcohol while taking this formulation, as it may increase the risk of adverse effects. Similarly, activities such as driving or operating heavy machinery should be avoided, as the formulation may cause drowsiness or dizziness.

It's important to note that this formulation may interact with other medications, including anticholinergics, antihistamines, and tricyclic antidepressants. Therefore, patients should inform their healthcare provider of all medications they are currently taking prior to starting this formulation.

This formulation should not be used in pregnant or breastfeeding women, as it may cause harm to the fetus or infant. If you have any questions about this formulation or its interactions, please consult with your healthcare provider.

Phenobarbital 24 mg/ml/Homatropine Methylbromide 0.27 mg/ml Oral Drops is a compounded liquid formulation that is used to treat a variety of conditions such as seizures, anxiety, and insomnia. This medication works by enhancing the activity of certain neurotransmitters in the brain, which aids in alleviating the symptoms associated with these conditions. The combination of phenobarbital and homatropine methylbromide in this formulation is designed to minimize the risk of side effects that may occur when either medication is taken individually.

The mechanism of action of this medication involves the augmentation of the activity of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter that plays a crucial role in reducing the activity of nerve cells in the brain, thereby helping to alleviate symptoms associated with seizures, anxiety, and insomnia.

The combination of phenobarbital and homatropine methylbromide in this formulation is designed to minimize the risk of side effects that may occur when either medication is taken individually. Some common side effects associated with this medication include drowsiness, dizziness, headache, nausea, and vomiting. It is important to contact your healthcare provider immediately if you experience any of these side effects.

It is crucial to take this medication exactly as prescribed by your healthcare provider. Do not take more or less than the recommended dose, and do not take it for a longer duration than prescribed. If you have any queries about how to take this medication, do not hesitate to reach out to your healthcare provider or pharmacist.

This compounded formulation of Phenobarbital 24 mg/ml and Homatropine Methylbromide 0.27 mg/ml is dispensed as oral drops. It is designed for precise and controlled administration, making it suitable for medications requiring smaller doses or for pediatric patients who may have difficulty swallowing tablets or capsules. The formulation is used to treat a variety of conditions and symptoms. It is effective in managing spasticity, a condition characterized by muscle stiffness and spasms. It is also used in the treatment of tetanus, a bacterial infection that causes muscle spasms and stiffness.

Furthermore, this formulation is beneficial in treating alcohol withdrawal symptoms, such as tremors, anxiety, and insomnia. It is also used to manage withdrawal symptoms from other drugs, including benzodiazepines. The Phenobarbital/Homatropine Methylbromide oral drops are also used to treat certain types of headaches, including cluster headaches and migraines.

Additionally, this formulation is effective in treating certain types of pain, such as neuropathic pain. It is also used in the management of certain psychiatric disorders, including bipolar disorder and schizophrenia. If you have any questions about the uses of this formulation, please reach out for further information.